Accedi a banche dati online | Convegnodetail
mail
Anteprima di stampa
 
 

Gene Therapy for Muscular Disorders

Evvnt Promotion / evvnt
-
21.02.2023 - 23.02.2023  Hilton Boston Back Bay, 40 Dalton Street, 02115 Boston, USA
Time: 9:30 am to 4:30 pm
 
Temi della conferenza
The past twelve months have seen an unprecedented level of excitement, investment, and progression within the gene therapy for muscular disorders field. As the industry endeavours to move gene therapy treatment through the preclinical and clinical pipeline, in context of reducing toxicity and increasing efficacy, attending the 3rd Annual Gene Therapy for Muscular Disorders Summit has never been so crucial.
Scientific organizer
Hanson Wade
Annotazioni
Brochure: https://go.evvnt.com/1443975-3?pid=4832

Speakers: Adam Cockrell, Senior Director of Vector Biology, AavantiBio, Alex Murphy, Senior Medical Director, Roche, Beatrice Darimont, Chief Scientific Officer, Cytoo and More
 

Informazioni ed Iscrizioni:

https://go.evvnt.com/1443975-2?pid=4832
Ms. Emily Birt
 
Categorie
Sanità Pubblica (Public Health), Servizi sanitari
Lingua
Inglese
Quote del Congresso
USD 2599.00 - USD 5396.00
I partecipanti attesi
1000
Contatto organizzatori
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Noi, Going International, siamo un’azienda che si è scelta come obiettivo di rendere acessibile la formazione a una grandissima quantità di persone, oltrepassanddo i confini geografici e sociali."

Österreichisches Rotes KreuzÄrzte der WeltCharité International AcademyAGEM - Arbeitsgemeinschaft Ethnologie und MedizinAnästhesie in Entwicklungsländern e. V.OÖ Gebietskrankenkasse, Referat für Wissenschaftskooperation AMREF - African Medical and Research FoundationSwiss Tropical and Public Health Institute